Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion
- PMID: 25384087
- DOI: 10.1038/nm.3734
Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion
Abstract
The dynamics of β-amyloid deposition and related second-order physiological effects, such as regional cerebral blood flow (rCBF), are key factors for a deeper understanding of Alzheimer's disease (AD). We present longitudinal in vivo data on the dynamics of β-amyloid deposition and the decline of rCBF in two different amyloid precursor protein (APP) transgenic mouse models of AD. Using a multiparametric positron emission tomography and magnetic resonance imaging approach, we demonstrate that in the presence of cerebral β-amyloid angiopathy (CAA), β-amyloid deposition is accompanied by a decline of rCBF. Loss of perfusion correlates with the growth of β-amyloid plaque burden but is not related to the number of CAA-induced microhemorrhages. However, in a mouse model of parenchymal β-amyloidosis and negligible CAA, rCBF is unchanged. Because synaptically driven spontaneous network activity is similar in both transgenic mouse strains, we conclude that the disease-related decline of rCBF is caused by CAA.
Similar articles
-
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.J Neurosci. 2005 Mar 16;25(11):2803-10. doi: 10.1523/JNEUROSCI.5170-04.2005. J Neurosci. 2005. PMID: 15772340 Free PMC article.
-
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.Acta Neuropathol Commun. 2016 Dec 12;4(1):130. doi: 10.1186/s40478-016-0399-z. Acta Neuropathol Commun. 2016. PMID: 27955679 Free PMC article. Clinical Trial.
-
99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.Mol Pharm. 2015 Aug 3;12(8):2937-46. doi: 10.1021/acs.molpharmaceut.5b00209. Epub 2015 Jun 25. Mol Pharm. 2015. PMID: 26065726
-
Animal models of cerebral amyloid angiopathy.Clin Sci (Lond). 2017 Sep 28;131(19):2469-2488. doi: 10.1042/CS20170033. Print 2017 Oct 15. Clin Sci (Lond). 2017. PMID: 28963121 Review.
-
Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update.Neuroimage Clin. 2017 May 5;15:247-263. doi: 10.1016/j.nicl.2017.05.002. eCollection 2017. Neuroimage Clin. 2017. PMID: 28560150 Free PMC article. Review.
Cited by
-
Quantitative multimodal multiparametric imaging in Alzheimer's disease.Brain Inform. 2016 Mar;3(1):29-37. doi: 10.1007/s40708-015-0028-9. Epub 2016 Jan 8. Brain Inform. 2016. PMID: 27747597 Free PMC article.
-
Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.Biomedicines. 2022 Aug 4;10(8):1890. doi: 10.3390/biomedicines10081890. Biomedicines. 2022. PMID: 36009437 Free PMC article. Review.
-
Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?J Clin Med. 2019 May 10;8(5):651. doi: 10.3390/jcm8050651. J Clin Med. 2019. PMID: 31083442 Free PMC article. Review.
-
Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer's disease.Photoacoustics. 2018 Apr 12;10:38-47. doi: 10.1016/j.pacs.2018.04.001. eCollection 2018 Jun. Photoacoustics. 2018. PMID: 29682448 Free PMC article.
-
Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research.Neurosci Bull. 2023 Jan;39(1):99-112. doi: 10.1007/s12264-022-00905-x. Epub 2022 Jun 30. Neurosci Bull. 2023. PMID: 35771383 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
